Rallybio Corporation (RLYB)
$16.72-0.42%Close
SELLBULL · day 101
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $89M
- Beta
- -0.85
- P/E (TTM)
- 2.11
- Short % float
- 1.71%
- Days to cover
- 4.9
- SI change
- -11.4%
- 1W
- -2.11%
- 1M
- +1.27%
- vs SPY 1W
- -1.97%
- vs SPY 1M
- -1.23%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on RLYB?
- LOPJLB’s latest quantitative signal on Rallybio Corporation (RLYB) is SELL in a BULL regime. Signals are updated daily.
- What market regime is RLYB in?
- Rallybio Corporation (RLYB) is currently classified in the BULL HMM market regime on LOPJLB.
- What does Rallybio Corporation (RLYB) do?
- Rallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for individuals facing severe and uncommon illnesses. Its most advanced therapeutic candidate, RLYB212, is a monoclonal anti-HPA-1a antibody currently undergoing Phase II clinical trials. This candidate, along with RLYB211, is aimed at preventing fetal and neonata…